NEWARK (CN) – A woman says Roche Laboratories’ acne drug Accutane and its generic form Claravis gave her such a bad case of inflammatory bowel disease she had to have her colon removed. Roche pulled the drug from the market in June 2009, but it was too late for her, Nazeena Gangji claims in Essex County Court.
Gangji says took the drug from 2006 until June 2009, when she was rushed to the hospital with inflammatory bowel disease so sever it required her to have her colon removed.
She sued Roche Laboratories, Barr Laboratories and Hoffmann-La Roche. Barr sold a generic form of the drug under the name Claravis, according to the complaint. Also known as Isotretinoin, it is a synthetic relative of vitamin A, and was developed by Hoffman-La Roche.
Gangji claims that until this day, Hoffman has “denied that there is sufficient scientific and medical knowledge to ascertain that the taking of Accutane caused plaintiff to develop inflammatory bowel disease (IBD), leading to the removal of her colon and other serious medical complications.” She adds that Roche still denies that any studies have shown that Accutane causes the disease.
She demands punitive damages. She is represented by Arnold Koenig of Hackensack, N.J.